Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study

NCT06161805 is registered in ClinicalTrials.gov with Reinier de Graaf Groep as lead sponsor.

NCT NCT06161805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esketamine as Treatment for Chronic Pain Due to Endometriosis: a RCT Study
Lead sponsor
Reinier de Graaf Groep
Phase
Phase 3
Overall status
Recruiting
Start date
March 1, 2024
Completion date
June 1, 2026
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pelvic pain syndrome, endometriosis